IL-33 released during liver resection facilitates intrahepatic cholangiocarcinoma growth via cytokine secretion in cancer-associated fibroblasts
- 23 November 2025
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 134 (3) , 519-529
Abstract
Background We previously reported that IL-33 released during hepatectomy contributes to cytokine-facilitated iCCA tumor growth. However, the underlying mechanisms of the tumor microenvironment remain unexplored. In this study, we aimed to elucidate the impact of IL-33 on cancer-associated fibroblasts (CAFs). Methods The abundance of IL-33-positive cells and alpha-SMA-positive fibroblasts (myoCAFs) was evaluated using resected specimens. Next-generation sequencing (NGS) was performed for comprehensive expression analysis. The effects of IL-33 stimulation on CAFs were investigated in vitro and in vivo using human and murine iCCA cell lines, as well as fibroblasts extracted from resected specimens. Results IL-33-positive cells and myoCAFs were significant risk factors for intrahepatic recurrence. NGS analysis revealed significant upregulation of various cytokines in cases with high number of IL-33-positive cells. The conditioned medium obtained from fibroblasts stimulated with IL-33 enhanced the proliferation and migration of iCCA cell lines. Among the cytokines that were increased by IL-33 stimulation in vitro, IL-6 was suspected to be the dominant. In a murine syngraft model, hepatectomy led to an increased subcutaneous tumor volume by releasing IL-33, whereas IL-6 blockade suppressed this growth. Conclusions This study indicated that IL-33 facilitates iCCA growth through fibroblast activation and is associated with intrahepatic recurrence.Keywords
This publication has 40 references indexed in Scilit:
- CD66b+ neutrophils and α‐SMA+ fibroblasts predict clinical outcomes and benefits from postoperative chemotherapy in gastric adenocarcinomaCancer Medicine, 2020
- Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinomaCancer Medicine, 2018
- Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular ProfilesCell Reports, 2017
- IL-33 in T Cell Differentiation, Function, and Immune HomeostasisTrends in Immunology, 2016
- Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy aloneCancer, 2015
- IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanismHepatology, 2015
- IL-33/ST2 pathway contributes to metastasis of human colorectal cancerBiochemical and Biophysical Research Communications, 2014
- The Interleukin-1 Family: Back to the FutureImmunity, 2013
- The paracrine effect of cancer‐associated fibroblast‐induced interleukin‐33 regulates the invasiveness of head and neck squamous cell carcinomaThe Journal of Pathology, 2013
- Comparative Analysis of Resection and Liver Transplantation for Intrahepatic and Hilar CholangiocarcinomaArchives of Surgery, 2011